Market Growth Factors:
Factors such as rising geriatric population, increase in the volume of surgeries and sports related-injuries, and increasing awarness about the medical implications of adhesion are expected to drive the growth of adhesion barrier market during the forecast period of 2018 to 2023.
However, reluctance among surgeons towards the usgage of adhesion barriers and the stringent regulations resulting in limited technological innovations may challenge market growth to a certain extent in the coming years.
Expert Analysis About The Market Growth:
The adhesion barrier market is projected to reach to USD 806.4 million by 2023 from estimated USD 570.7 million in 2018, at a CAGR of 7.2%.
Market Segmentation:
In this report, the adhesion barriers market is categorized based on product, formulation, application, and region.
Download FREE Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208132543
The neurological surgeries segment is expected to register the highest CAGR during the forecast period
Based on applications, the adhesion barriers market is segmented into gynecological surgeries, general/abdominal surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, reconstructive surgeries, urological surgeries, and other surgeries (such as ear, nose, throat, and burn surgeries). The neurological surgeries segment is estimated to register the highest CAGR during the forecast period. The growth of this segment is driven by the increasing focus of players on developing adhesion barrier gels for neurological surgeries.
Asia Pacific to witness the highest growth during the forecast period
Asia Pacific is expected to witness the highest growth during the forecast period (2018 to 2023). The region’s large geriatric population, large patient population, improving healthcare infrastructure, growing medical tourism, and epidemiological shift from infectious to chronic diseases are driving the growth of this market.
The report analyzes the adhesion barrier market and aims at estimating the market size and future growth potential of this market based on various segments such as product, formulation, application, and region. The report also includes a product portfolio matrix and product pipeline analysis of adhesion barriers available in the market and are under one of the clinical trial phases respectively. The report also provides competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Request Sample Report Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=208132543
Key Market Players:
Johnson & Johnson (J&J) (US), Sanofi (France), and Baxter International (US) dominated the global adhesion barrier market in 2017. Some of the other players competing in this market are C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea).
Factors such as rising geriatric population, increase in the volume of surgeries and sports related-injuries, and increasing awarness about the medical implications of adhesion are expected to drive the growth of adhesion barrier market during the forecast period of 2018 to 2023.
However, reluctance among surgeons towards the usgage of adhesion barriers and the stringent regulations resulting in limited technological innovations may challenge market growth to a certain extent in the coming years.
Expert Analysis About The Market Growth:
The adhesion barrier market is projected to reach to USD 806.4 million by 2023 from estimated USD 570.7 million in 2018, at a CAGR of 7.2%.
Market Segmentation:
In this report, the adhesion barriers market is categorized based on product, formulation, application, and region.
Download FREE Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208132543
The neurological surgeries segment is expected to register the highest CAGR during the forecast period
Based on applications, the adhesion barriers market is segmented into gynecological surgeries, general/abdominal surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, reconstructive surgeries, urological surgeries, and other surgeries (such as ear, nose, throat, and burn surgeries). The neurological surgeries segment is estimated to register the highest CAGR during the forecast period. The growth of this segment is driven by the increasing focus of players on developing adhesion barrier gels for neurological surgeries.
Asia Pacific to witness the highest growth during the forecast period
Asia Pacific is expected to witness the highest growth during the forecast period (2018 to 2023). The region’s large geriatric population, large patient population, improving healthcare infrastructure, growing medical tourism, and epidemiological shift from infectious to chronic diseases are driving the growth of this market.
The report analyzes the adhesion barrier market and aims at estimating the market size and future growth potential of this market based on various segments such as product, formulation, application, and region. The report also includes a product portfolio matrix and product pipeline analysis of adhesion barriers available in the market and are under one of the clinical trial phases respectively. The report also provides competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Request Sample Report Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=208132543
Key Market Players:
Johnson & Johnson (J&J) (US), Sanofi (France), and Baxter International (US) dominated the global adhesion barrier market in 2017. Some of the other players competing in this market are C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea).
Comments
Post a Comment